3 No-Brainer Growth Stocks to Buy With $100 Right Now

Investing in growth stocks can be a great way to build wealth over time, but finding the right ones can be challenging. If you're looking for growth stocks that are relatively affordable and have strong growth potential, consider these three options:

1. CRISPR Therapeutics (CRSP)
* CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies.
* The company recently received approval for its first therapy, Casgevy, which treats sickle cell disease and beta-thalassemia.
* Casgevy has a price tag of over $2 million, which should generate significant revenue for CRISPR.
* The company's stock is trading at just over $51 a share, making it an attractive buy for investors looking for growth at a relatively low price point.
* CRISPR is a safer stock to consider than many other small biotech stocks with no approved products in their portfolios.

2. Celsius (CELH)
* Celsius is an energy drink company that has been facing some headwinds recently, but it still has promising characteristics that make it an attractive growth investment.
* PepsiCo is a key distributor and investor in Celsius, having made a $550 million investment in the company in 2022. This is a great vote of confidence from a well-known and respected partner.
* Celsius has posted an operating profit in three of its past four quarters, indicating that the company is on solid financial footing.
* Celsius' stock is trading for less than $30, making it an attractive buy for investors looking for growth at a relatively low price point.

3. KB Home (KBH)
* KB Home is a homebuilding company that is well-positioned to benefit from favorable market conditions, such as lower interest rates.
* The company is rated as a top homebuilder in the U.S. and has been experiencing strengthening demand in recent quarters.
* KB Home's stock is trading at just 11 times its trailing earnings, making it an attractive buy for investors looking for growth at a relatively low price point.
* KB Home's revenue for the period ending Aug. 31 totaled around $1.8 billion and rose by more than 10% from the same period last year, indicating that the company is on a solid growth trajectory.

These three stocks offer a combination of growth potential, attractive valuations, and strong fundamentals. While there may be some risk involved in investing in these stocks, their growth prospects and relatively low price points make them attractive options for investors looking to build long-term wealth.